Archive: May 2022
Feature
Single-Use Duodenoscopes for ERCP: Rationale, Feasibility, Cost, and Environmental Impact
Abstract: Recent outbreaks of duodenoscope-associated multidrug-resistant organism infections have increased awareness and concern about the pitfalls in high-level disinfection protocols and duodenoscope design. A call for […]
Feature
Shooting for the Stars: Review of the STARDUST Trial and the Treat-to-Target Approach for Crohn’s Disease
Abstract: Crohn’s disease (CD) and ulcerative colitis, collectively termed inflammatory bowel disease, are progressive autoimmune conditions of the gastrointestinal tract. Mucosal healing has been associated with […]
Advances in GERD
Novel Screening and DNA Testing for the Detection of Esophageal Precancerous Disease
G&H Why have screening rates for esophageal cancer historically been low? DP The biggest reason is a lack of awareness and understanding of esophageal cancer, particularly […]
Advances in Hepatology
Screening for Hepatitis B Virus and Tuberculosis
G&H Currently, how common is coinfection of hepatitis B virus and tuberculosis (active or latent) in the United States? AC It is challenging to assess estimates […]
Advances in IBD
Reviewing the Use of Vedolizumab for the Treatment of Patients With Crohn’s Disease
G&H What is the current indication for vedolizumab in patients with Crohn’s disease? SH Vedolizumab (Entyvio, Takeda) is currently indicated for the treatment of moderate to […]
Feature
Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease
Abstract: The armamentarium of medical therapy for inflammatory bowel disease (IBD) has expanded significantly during the past decade. A major change has been the introduction of […]
Letter From the Editor
Letter From the Editor: Treatment for Patients With Inflammatory Bowel Disease
There has been a significant expansion in the options for inflammatory bowel disease (IBD) treatment over the past decade. A number of articles in this month’s […]